tiprankstipranks
Trending News
More News >

MediciNova receives gene therapy milestone payment

MediciNova (MNOV) announced that it has received a milestone payment under MediciNova’s assignment agreement with Genzyme Corporation, a subsidiary of Sanofi (SNY). The milestone payment of $1M is the result of the successful achievement of a clinical development milestone for a gene therapy product based on AAV vector technology that is covered under the assignment agreement.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on MNOV:

Disclaimer & DisclosureReport an Issue